Skip to main content
. 2026 Sep 30;16(19):3184. doi: 10.3390/diagnostics16193184
5-ASA 5-aminosalicylic acid (mesalazine/mesalamine)
ADA adalimumab
AZA azathioprine
BD Behçet’s disease
CENTRAL Cochrane Central Register of Controlled Trials
CINAHL Cumulative Index to Nursing and Allied Health Literature
COL colchicine
CS corticosteroids
CSA cyclosporine A
CYC cyclophosphamide
EN enteral nutrition
ETN etanercept
GI gastrointestinal
GI-PedBD gastrointestinal involvement in pediatric Behçet’s disease
IBD inflammatory bowel disease
ICBD International Criteria for Behçet’s Disease
IFX infliximab
ISG International Study Group (criteria)
JBI Joanna Briggs Institute
MMF mycophenolate mofetil
MPDN methylprednisolone
MTX methotrexate
PDN prednisolone/prednisone
PedBD pediatric Behçet’s disease
PEDBD Pediatric Behçet’s Disease (classification criteria)
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
SSZ sulfasalazine/salazosulfapyridine
TAC tacrolimus
THAL thalidomide
TNF tumor necrosis factor
TPN total parenteral nutrition